TURNOVER (x1000 EUR)
NET PROFIT (x1000 EUR)
EMPLOYEES
Ophtadoc AB
Closing information (x1000 EUR)
Closing information | 2024/12 | 2023/12 | 2022/12 |
Turnover |
481
|
373 | |
Financial expenses |
0
![]() |
0 | |
Earnings before taxes |
289
|
211 | |
EBITDA |
286
|
179 | |
Total assets |
755
|
536 | |
Current assets |
755
|
536 | |
Current liabilities |
103
|
66 | |
Equity capital |
591
|
422 | |
- share capital |
5
|
4 | |
Employees (average) |
1
|
2
![]() |
2 |
Financial ratios
Fiscal year | 2024/12 | 2023/12 | 2022/12 |
Solvency |
78.3%
|
78.7% | |
Turnover per employee |
240
|
186 | |
Profit as a percentage of turnover |
60.1%
|
56.6% | |
Return on assets (ROA) |
38.3%
|
39.4% | |
Current ratio |
733.0%
|
812.1% | |
Return on equity (ROE) |
48.9%
|
50.0% | |
Change turnover |
106
|
40 | |
Change turnover % |
37%
|
28%
|
12% |
Chg. No. of employees |
-1
|
0
![]() |
0 |
Chg. No. of employees % |
-50%
|
0%
![]() |
0% |
Total value of public sale
Fiscal year | 2024/12 | 2023/12 | 2022/12 |
Total value of public sale |
0
![]() |
0
![]() |
0 |
Closing figures are converted to the currency above at the exchange rate of the closing date. Source for the exchange rates: Sveriges Riksbank
The closing information is gathered directly from the companies or from Creditsafe.